Form 4: Director Tess Roering Receives NATR Equity Grant

Nature's Sunshine Products director Tess Roering was granted 4,500 restricted stock units as part of company compensation.

Summary

• Director Tess Roering acquired 4,500 restricted stock units (RSUs) of Nature's Sunshine Products, Inc. (NATR).
• The transaction occurred on May 15, 2026.
• Each RSU represents a right to receive one share of common stock at no cost.
• Following this transaction, the reporting person holds a total of 34,427 shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of RSUs is subject to time-based conditions or the occurrence of the annual shareholder meeting.

Future Outlook

The RSUs are scheduled to vest on May 15, 2027, or upon the date of the company's annual shareholder meeting, whichever occurs first.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the consumer health and wellness sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for mid-cap companies in the health and wellness industry.
• The vesting schedule aligns with typical one-year cliff vesting cycles observed in similar publicly traded entities.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the 4,500 RSUs on May 15, 2027, or the next annual shareholder meeting.

Key Dates

Keywords

NATR, Nature's Sunshine Products, Form 4, Insider Trading, Equity Compensation, Director